$RKLB

Spice Adam C. sold $3.5M of RKLB

Spice Adam C. (Chief Financial Officer) sold 24,436 shares of Rocket Lab Corp (RKLB) at $143.24 ($3.50M total) on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Spice Adam C.
Published May 29, 2026, 12:59 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

This is a disclosed ownership change, not an operational or financial update. The 10b5-1 designation typically lowers the probability that the sale signals new negative information.

02

Market read

Provides a concrete insider-selling datapoint for RKLB, but with reduced interpretive weight due to the pre-arranged 10b5-1 plan.

03

What to watch

Traders may overweight the headline sale size; the filing date vs. transaction date (filed May 28 for May 26 sale) can also reduce immediate trading relevance.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed May 28 for a May 26 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Rocket Lab’s CFO, including trade size, price, and 10b5-1 status.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab CFO Spice Adam sold $3.5M of RKLB shares via an open-market transaction under a 10b5-1 plan.

Expected impact

Near-term impact likely muted; any reaction would be more sentiment/positioning than new fundamentals.

Evidence & confidence

Form 4 provides a concrete datapoint (sale size/date/price) but explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Could marginally affect sentiment for space/launch names if traders extrapolate insider behavior, but no direct sector catalyst is provided.

No clear regional linkage beyond US small/mid-cap growth sentiment.

Limited—this is company-specific insider transaction disclosure without broader deal/regulatory implications.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations; price may ignore it.

Key entities

  • Rocket Lab Corp

    Subject of the SEC Form 4 insider sale by CFO Spice Adam.

  • Spice Adam

    Rocket Lab CFO who executed the open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Is RKLB Stock A Buy Or A High-Beta Trap?

Rocket Lab (RKLB) trades at $66, down 56% from its 52-week high, with a high P/S ratio. Q2 2026 revenue was $234M, up 62% YoY, mainly from Space Systems. Neutron rocket launch and Iridium acquisition are delayed. Backlog is $2.36B. Management expects slow growth from Iridium.

$RKLBHighAI 8/10

Rocket Lab Falls 6% as SpaceX Flags Iridium Deal to the FCC, Intuitive Machines Slides 5%

Rocket Lab (RKLB) fell 6% to $63.82 after SpaceX filed an FCC complaint against Iridium, which could impact Rocket Lab's $8B acquisition. The deal's variable exchange ratio ties Iridium payouts to Rocket Lab's share price, amplifying regulatory risks. Intuitive Machines (LUNR) and AST SpaceMobile (ASTS) also slid 5% and 6% respectively, following broader sector weakness.

$RKLBHighAI 9/10

Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab (RKLB), a smaller competitor to SpaceX (SPCX), has developed HASTE, a suborbital launch vehicle for hypersonic testing, primarily for the Department of Defense. HASTE offers lower-cost, frequent testing, generating higher revenue per flight than standard Electron launches. Rocket Lab has secured around $500 million in HASTE contracts, contributing significantly to its projected 2026 revenue. The company also operates in satellite manufacturing and plans to expand with the acquisition

$INTCHighAI 8/10

Why Are Nasdaq, Dow Futures Trading Mixed Premarket? INTC, SLS, SPCX, RKLB, ASTS, RIOT, FRMI Stocks Are In Focus

U.S. stock futures were mixed on Tuesday, with Nasdaq and Russell 2000 futures up 0.1%, Dow futures down 0.1%, and S&P 500 futures flat. Investors await July CPI data and geopolitical tensions impact sentiment. Key earnings reports include SMCI, CRWV, CAVA, LITE, and SLS. NVDA labeled AI data centers as investable assets, INTC upsized its share sale to $20B, and RIOT secured a $9.1B deal. RKLB shares fell despite a revenue beat, ASTS extended selloff, and SPCX faced lockup expiration pressures.

$RKLBMedAI 8/10

Rocket Lab Stock: Bull vs. Bear

Rocket Lab (RKLB +2.04%) reported record revenue of $234M in Q2 2026, up 62% YoY, with a backlog of $2.36B. The company secured U.S. Space Force contracts but delayed its Neutron rocket launch. Despite growth, it trades at 51x sales and reported a $49M net loss in Q2. Neutron's success is critical for future profitability.